Cardiodiabetes update : a textbook of cardiology / H.K. Chopra [and five others] (editors).

Format:

Book

Contributor:

Chopra, H. K., editor.

Language:

English

Subjects (All):

Heart--Diseases.

Heart.

Physical Description:

1 online resource (xxxi, 891 pages)

Edition:

1st ed.

Place of Publication:

New Delhi, India ; London ; Panama : Jaypee The Health Sciences Publishers, [2018]

Summary:

This book focuses on Cardiodiabetes Update: A Textbook of Cardiology. In the world, the scenario of prevalence of cardiometabolic syndrome varies from 60-90%. The prevalence of cardiometabolic syndrome in India varies from 40-65% and is prevalent, to a large extent, in Punjab and Kerala, in India. The prevalence rate of central obesity in the cardiometabolic syndrome varies from 80-90%|and, hypertension 70-80%. The rising menace of this hidden medical terrorist has reached pandemic proportions worldwide. It is a predictor of premature abnormal 'cardiovascular thrombo-inflammatory chain'. It comprises nine sections, including clinical spectrum, diagnosis, management strategies, nutraceutical and obesity care, arrhythmia management, intervention, cardiac surgery, rehabilitation, and future directions, including a total of 132 chapters. Each chapter addresses a separate and distinct issue of clinical relevance. The chapters are well-outlined, organized, well-written and referenced. The writing style of every chapter is vivid, concise and practical. There are excellent graphics, tables and figures and flow charts that present the relevant information. The printing and binding is of excellent quality. This book serves as an important reference guide for the postgraduate students, fellows, internists, cardiologists, endocrinologists, nephrologists, neurologists, critical care physicians, pulmonologists, pediatricians, pediatric surgeons, cardiovascular surgeons, dermatologists, gynecologists, imaging experts and nutritionists, etc.

Contents:

Cover

Disclaimer

Book Title

Copyright Page

Co-Editors

Dedicated

Contributors

Foreword

Preface

Contents

Section-1: Clinical Spectrum

Chapter-1: Clinical Spectrum of Cardiodiabetes: How Indians are Different

Chapter-2: Risk Factors for Cardiodiabetes

Chapter-3: Cardiodiabetes in Children

Chapter-4: New Genes for Type 2 Diabetes: Indian Scenario

Chapter-5: Stress and Cardiodiabetes

Chapter-6: Hypothyroidism and Cardiodiabetes

Chapter-7: Cardiodiabetes and Insulin Resistance in Obesity: Clinical Relevance

Chapter-8: Anemia and Cardiodiabetes: Management Strategies

Chapter-9: Endothelial Dysfunction in Atrial Fibrillation with Type 2 DM

Chapter-10: ACS, Cardiodiabetes, and Women

Chapter-11: Coronary Artery Disease in Diabetes: How Different is It from Nondiabetics?

Chapter-12: Cardiodiabetes and Heart Failure in the Elderly

Chapter-13: Prognosis of Heart Failure in Diabetes: Newer Perspectives

Chapter-14: Cardiodiabetes Management and STEMI: Prognostication

Chapter-15: Small Vessel CAD in Cardiodiabetes

Chapter-16: Cardiodiabetes and Deep Venous Thrombosis

Chapter-17: Pregnancy and Cardiodiabetes

Chapter-18: Cardiodiabetes and Autonomic Insufficiency

Chapter-19: Cardiodiabetes and Pulmonary Embolism: Is the Outcome Different?

Chapter-20: Cardiodiabetes and Cutaneous Manifestations

Chapter-21: Benidipine for Hypertension in Chronic Kidney Disease with Cardiodiabetes

Chapter-22: Cardiorenal Diabetes: Triple Jeopardy

Chapter-23: Contrast-induced Acute Kidney Injury

Chapter-24: Cardiodiabetes and Hypertension: Double Jeopardy

Chapter-25: Cardiodiabetes and Obstructive Sleep Apnea

Chapter-26: Cardiodiabetes and Mind-Heart Connection

Chapter-27: Aortic Aneurysm Surgery in Cardiodiabetes: Is the Outcome Different?.

Chapter-28: Cardiodiabetes and Syncope

Chapter-29: Cardiodiabetes and Sexual Dysfunction

Chapter-30: Cardiodiabetes and Erectile Dysfunction

Chapter-31: Endothelial Cell Dysfunction in DM, HT and CAD, and Its Pathophysiology

Section-2: Diagnosis

Chapter-32: Current Status of Diabetic Cardiomyopathy

Chapter-33: Insulin Therapy and Cardiodiabetes

Chapter-34: Echo-guided CRT in Cardiodiabetes

Chapter-35: Echocardiography in Diabetes

Chapter-36: Echo/Doppler Assessment of Increased Left-sided Filling Pressures and Diastolic Heart Failure in Patients with Normal Systolic Function in Cardiodiabetes

Chapter-37: 3D Echo and Cardiodiabetes

Chapter-38: Emergency Echocardiography in Cardiodiabetes

Chapter-39: Diabetic Cardiomyopathy: Studies on Global Longitudinal Strain in Asymptomatic Diabetic Subjects

Chapter-40: Strain and Strain Rate Imaging in Cardiodiabetes

Chapter-41: Dobutamine Stress Echo for Coronary Artery Disease Evaluation in Diabetics

Chapter-42: Noninvasive Cardiovascular Imaging for Risk Assessment in Asymptomatic Diabetic Patients

Chapter-43: Value of Ankle-Brachial Index in Cardiodiabetes

Chapter-44: Computed Tomography Evaluation of Abdominal Arterial Wall Calcification in Patients with Type 2 Diabetes Mellitus

Chapter-45: Cardiac MRI: A Promise, Hope or Hype in Cardiodiabetes

Chapter-46: CT for CVD Evaluation in Cardiodiabetes

Chapter-47: Recent Advances in Nuclear Cardiology and Cardiodiabetes

Chapter-48: Blood Pressure Variability in Cardiodiabetes

Chapter-49: Central Aortic Blood Pressure Evaluation for Hypertension in Cardiodiabetics

Chapter-50: Telemedicine in Diabetes Management

Chapter-51: HbA1c: Clinical Relevance in Cardiodiabetes

Chapter-52: Emerging Role of Cardiac Troponin in Cardiodiabetes

Section-3: Management Strategies.

Chapter-53: Role of Yoga in Cardiodiabetes

Chapter-54: Metabolic Effects of Antihypertensive Drugs

Chapter-55: Potential Role of Rosuvastatin in Cardiodiabetes

Chapter-56: Diabetic Hypertriglyceridemia: Management Strategies

Chapter-57: High-density Lipoprotein in Cardiodiabetes

Chapter-58: Glucose-lowering Strategies and Cardiovascular Outcomes

Chapter-59: Improving CV Outcomes in Diabetes with New Antidiabetic Medications: A New Era has Begun

Chapter-60: Positioning of Once Weekly GLP-1-based Therapies for Whom and When?

Chapter-61: DPP-IV Inhibitors beyond Glycemic Efficacy

Chapter-62: Insulin Therapy and Cardiodiabetes in Critical Care

Chapter-63: Lixisenatide: A Cardiodiabetes Perspective

Chapter-64: SGLT2-i Agents and Cardiovascular Diabetology

Chapter-65: SGLT2-i for the Reduction of Cardiovascular Events in High-risk Patients with Diabetes Mellitus

Chapter-66: Diabetes and Heart Failure: New Data on the Role of SGLT 2 Inhibitors-A Change of Concept?

Chapter-67: Bisoprolol: Is It Superior in Cardiodiabetes?

Chapter-68: Bisoprolol: A Choice of Beta Blocker in Hypertension and ACS in Cardiodiabetes

Chapter-69: Bisoprolol in Heart Failure in Cardiodiabetes

Chapter-70: Nebivolol for Hypertension in Cardiodiabetes

Chapter-71: ARB for Hypertension in Cardiodiabetes

Chapter-72: CKD and Hypertension: Is Benidipine Beneficial?

Chapter-73: Azilsartan: Promise and Power for Hypertension in Cardiodiabetes

Chapter-74: Benidipine for Hypertension in Cardiodiabetes

Chapter-75: Azilsartan: A Molecule of First Choice for Hypertension in Cardiodiabetes

Chapter-76: Superiority of Telmisartan: ARB, the First Choice in Cardiodiabetes

Chapter-77: ARNI in Heart Failure with Cardiodiabetes: The Way Forward.

Chapter-78: Indapamide versus Hydrochlorothiazide versus Chlorthalidone in Cardiodiabetes

Chapter-79: Polypill for Cardiovascular Protection in Diabetes

Chapter-80: Clopidogrel in Patients of Diabetes with Acute Coronary Syndrome

Chapter-81: Acute Coronary Syndrome in Cardiodiabetes: Is It Different?

Chapter-82: Newer Drugs in Heart Failure and Changes in Our Clinical Approach

Chapter-83: Role of Oral Anticoagulants in Atrial Fibrillation with Cardiodiabetes

Chapter-84: Low-molecular-weight Heparin in Acute Coronary Syndrome in Cardiodiabetes

Chapter-85: Myocardial Bridging

Chapter-86: Benidipine for Hypertension in STEMI with Cardiodiabetes

Chapter-87: Thrombolytic Therapy of Choice in STEMI with Cardiodiabetes

Chapter-88: Tenecteplase and ST-elevation Myocardial Infarction with Cardiodiabetes

Chapter-89: Cardiodiabetes and Stroke

Chapter-90: Hemorrhagic Stroke and Cardiodiabetes

Chapter-91: Prognostication of STEMI in Cardiodiabetes

Chapter-92: Management of Hypertension in Diabetes: Special Consideration

Chapter-93: Benidipine: A New Calcium Channel Blocker for Management of Hypertension and Angina in Cardiodiabetes

Chapter-94: Azilsartan for Hypertension Management in Cardiodiabetes

Chapter-95: Need for Registry of Cardiodiabetes in India

Chapter-96: Nonpharmacological Management of Cardiodiabetes

Chapter-97: Maternal Diabetes Mellitus and Fetal Cardiac Malformations: Antenatal and Postnatal Management and Outcome

Chapter-98: Role of Enhanced External Counterpulsation: Future Perspectives

Section-4: Nutraceutical and Obesity Care

Chapter-99: Role of Vitamin D as Cardioprotection Strategy: Hope or Hype?

Chapter-100: Omega-3 Fatty Acids and Cardiovascular Disease

Chapter-101: Role of Red Yeast Rice and Phytosterols in Dyslipidemia.

Chapter-102: Meal Replacement Therapy for Obesity Care in Cardiodiabetes

Chapter-103: Ideal Edible Oil in Cardiodiabetes

Chapter-104: Cardiodiabetic Diet

Section-5: Arrhythmia Management

Chapter-105: Cardiodiabetes and Heart Rate Variability

Chapter-106: Natural History of Atrial Fibrillation in Cardiodiabetes: Is it Different?

Chapter-107: Atrial Fibrillation: Management Strategies in Cardiodiabetics

Chapter-108: Ventricular Tachycardia in Heart Failure with Cardiodiabetes

Chapter-109: Sudden Cardiac Death in Patients with Diabetes Mellitus: Prevalence, Predictors and Preventive Strategies

Chapter-110: Prevention of Sudden Cardiac Death in Cardiodiabetes

Chapter-111: Pacing in Cardiodiabetes

Chapter-112: Radiofrequency Ablation in Atrial Fibrillation in Cardiodiabetes

Chapter-113: LA Appendage Closure for AF in Cardiodiabetes: Is the Outcome Different?

Chapter-114: AICD after Cardiac Arrest in Cardiodiabetes

Section-6: Intervention

Chapter-115: Coronary Interventions in Cardiodiabetes Prognostication

Chapter-116: Primary PCI for STEMI in Cardiodiabetes: What is the Outcome?

Chapter-117: Optimizing Results of Percutaneous Coronary Intervention in Multivessel Disease with Diabetes

Chapter-118: STEMI Management in Diabetes Mellitus: Is it Different?

Chapter-119: CTO with STEMI in Cardiodiabetes: Is the Outcome Different?

Chapter-120: Coronary Intervention in Venous Grafts in Diabetes

Chapter-121: Cardiodiabetes and Peripheral Vascular Interventions

Chapter-122: Cardiodiabetes and Vasculopathy

Chapter-123: Cardiodiabetes and Carotid Artery Interventions

Chapter-124: Coronary Revascularization in Diabetics

Chapter-125: Endovascular Intervention in Stroke in Cardiodiabetes: New Frontiers

Section-7: Cardiac Surgery

Chapter-126: Coronary Artery Bypass Grafting in Cardiodiabetes.

Chapter-127: Cardiac Surgery and Diabetes.

Notes:

Includes index.

Description based on print version record.

ISBN:

93-90020-24-7